FDA recall, , Moderate risk
LifeStream Blood Bank Red Blood Cells, Leukocytes Reduced
Red blood cells labeled as leukocytes reduced were not tested to verify white blood cell count.
Recall ended Sep 24, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
LifeStream Blood Bank initiated a recall of one unit of Red Blood Cells, Leukocytes Reduced on July 29, 2025. The product was labeled as leukocytes reduced but was not tested to verify white blood cell count. The recall was added to the FDA's Enforcement Report and classified on September 24, 2026, and involved distribution in California.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- LifeStream Blood Bank
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99088
- Recall number
- B-0210-2026
- Quantity recalled
- 1 unit
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
